Gene knockouts of c-src, transforming growth factor β1, and tenascin suggest superfluous, nonfunctional expression of proteins

Journal of Cell Biology

Volumn 120, Issue 5, 1993, Pages 1079-1081

  Erickson, Harold P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

EMBRYONAL TISSUE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; IMMUNOCYTOCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REVIEW;

ANIMAL; CELL ADHESION MOLECULES, NEURONAL; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENES, SRC; MICE; MUTAGENESIS, INSERTIONAL; NERVE GROWTH FACTORS; PROTO-ONCOGENE PROTEIN PP60(C-SRC); TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027446459     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.120.5.1079     Document Type: Review

References (17)

1. Braun, T., M. A. Rudnicki, H.-H. Arnold, and R. Jaenisch. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell. 71:369-382.
2. Brookfield, J. 1992. Can genes be truly redundant? Curr. Biol. 2:553-554.
3. Erickson, H. P., and M. A. Bourdon. 1989. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5:71-92.
4. Gitelman, S. E., J. Bristow, and W. L. Miller. 1992. Mechanism and consequences of the duplication of the human C4/P450c21/Gene X locus. Mol. Cell. Biol. 12:2124-2134.
5. c-src in association with intracellular membranes. J. Cell Biol. 119:1003-1013.
6. Joyner, A. L., K. Herrup, B. A. Auerbach, C. A. Davis, and J. Rossant. 1991. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science (Wash. DC). 251:1239-1243.
7. Matsumoto, K., N. Ishihara, A. Ando, H. Inoko, and T. Ikemura. 1992. Extracellular matrix protein tenascin-like gene found in human MHC class III region. Immunogenetics. 36:400-403.
8. Millan, F. A., F. Denhez, P. Kondaiah, and R. J. Akhurst. 1991. Embryonic gene expression patterns of TGFβ1, β2 and β3 suggest different developmental fonctions in vivo. Development (Camb.). 111:131-143.
9. Nörenberg, U., H. Wille, J. M. Wolff, R Frank, and F. G. Rathjen. 1992. The chicken neural extracellular matrix molecule restriction: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron. 8:849-863.
10. Nowak, R. 1991. c-src's cellular role astounds researchers. J. NIH Res. 3:54-58.
11. Pelton, R. W., B. Saxena, M. Jones, H. L. Moses, and L. I. Gold. 1991. Immunohistochemical localization of TGFβ1. TGFβ2. and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1091-1105.
12. Pesheva, P., E. Spiess, and M. Schachner. 1989. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J. Cell Biol. 109:1765-1778.
13. Rudnicki, M. A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 71:383-390.
14. Saga, Y., T. Yagi, Y. Ikawa, T. Sakakura, and S. Aizawa. 1992. Mice develop normally without tenascin. Genes Dev. 6:1821-1831.
15. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
16. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702.
17. Thoenen, H., and Y. -A. Barde. 1980. Physiology of nerve growth factor. Physiol. Rev. 60:1284-1335.